LV systolic dysfunction in humans with SAH is associated with normal myocardial perfusion and abnormal sympathetic innervation. These findings may be explained by excessive release of norepinephrine from myocardial sympathetic nerves, which could damage both myocytes and nerve terminals.
Background and Purpose-Cardiac abnormalities occur commonly after subarachnoid hemorrhage (SAH) and may be caused by excessive release of catecholamines from the myocardial sympathetic nerves. We hypothesized that adrenoceptor polymorphisms resulting in greater catecholamine sensitivity would be associated with an increased risk of cardiac injury. Methods-This was a prospective cohort study. The primary outcome variables were the serum level of cardiac troponin I (cTi, abnormal if Ͼ1.0 g/L) and the left ventricular ejection fraction (LVEF, abnormal if Ͻ50%). Six adrenoceptor polymorphisms were genotyped: 1AR Arg389Gly, 1AR Ser49Gly, 2AR Gly16Arg, 2AR Gln27Glu, 2AR Thr164Ile, and ␣2AR del322-325. The effect of each polymorphism on the risk of developing cardiac abnormalities was quantified using multivariable logistic regression. Results-The study included 182 patients. The CC genotype (Arg/Arg) of 1AR Arg389Gly (odds ratio [OR] 3.4, Pϭ0.030) and the CC genotype (Gln/Gln) of 2AR Gln27Glu (OR 3.1, Pϭ0.032) were predictive of cTi release. The presence of the ␣2AR deletion was predictive of reduced LVEF (OR 4.2, Pϭ0.023). The combination of the 1AR 389 CC and the 2AR 27 CC genotypes resulted in a marked increase in the odds of cTi release (OR 15.5, Pϭ0.012). The combination of the 1AR 389 CC and the ␣2AR deletion genotypes resulted in a marked increase in the odds of developing a reduced LVEF (OR 10.3, Pϭ0.033). Conclusions-Genetic polymorphisms of the adrenoceptors are associated with an increased risk of cardiac abnormalities after SAH. These data support the hypothesis that cardiac dysfunction after SAH is a form of neurocardiogenic injury.
Cardiovascular abnormalities are independent predictors of in-patient mortality after SAH. Though these effects may be explained by a reduction in cerebral perfusion pressure or other mechanisms, further research is required to determine whether or not they are causal in nature.
In the acute period after SAH, hypernatremia is associated with adverse cardiac outcomes and death. SAH patients with hypernatremia should be monitored for evidence of cardiac dysfunction.
Diastolic dysfunction is common after SAH. It is associated with history of hypertension and older age and may explain the development of pulmonary edema in many SAH patients.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.